Mucopolysaccharidoses

Mucopolysaccharidosis, Type II_ MPS2 OMIM #309900
*This composite image of Mucopolysaccharidoses was created to help geneticists get a better analysis

What are Mucopolysaccharidoses?

Mucopolysaccharidoses refers to a group of inherited metabolic disorders. There are 7 specific genetic disorders within this group. The condition is progressive, and symptoms can vary significantly, even among individuals within the same family. Most individuals are diagnosed in either childhood or adolescence.

The Mucopolysaccharidoses group of disorders affects around 1 in 25,000 children a year.

Health conditions related to the syndrome may include heart and respiratory disease and severe sleep apnea. Enlarged organs are also a potential health complication in individuals with the syndrome. Shared characteristics of all mucopolysaccharidoses include growth and/or developmental delay, coarse facies, skeletal dysplasia, hernia, and corneal clouding.

What gene change causes Mucopolysaccharidoses?

Individuals with Mucopolysaccharidoses either lack or have malfunctioning lysosomal enzymes. These enzymes are responsible for breaking down glycosaminoglycans, or complex carbohydrates within the body. When they are missing or malfunctioning, it leads to a build of carbohydrates in the cells, blood, brain, and spinal cord, leading to cellular damage.

Most mucopolysaccharidoses are autosomal recessive disorders, except for type II, which is X-linked recessive.

What are the main symptoms of Mucopolysaccharidoses?

The main symptoms of Mucopolysaccharidoses may vary between individuals and may also vary in the extent of their severity. The condition is progressive, and most individuals deteriorate over time in terms of their health condition.

Common symptoms in the early stages of diagnosis include frequent colds and growth and developmental delays. Typical facial features include a flat nasal bridge, thick lips, an enlarged mouth, and jaw. Dwarfism, dysplasia, and excess body hair are other possible symptoms.

Possible clinical traits/features:
Limitation of joint mobility, Decreased nerve conduction velocity, Coarse facial features, Everted lower lip vermilion, Obstructive sleep apnea, Sensorineural hearing impairment, Pes cavus, Autosomal recessive inheritance, Short neck, Wide mouth, Sinusitis, Retinal degeneration, Wide nose, Broad face, Abnormal aortic valve morphology, Mucopolysacchariduria, Cerebral palsy, Aortic valve stenosis, Aortic regurgitation, Intellectual disability, Mandibular prognathia, Splenomegaly, Thick lower lip vermilion, Glaucoma, Full cheeks, Genu valgum, Depressed nasal bridge, Hypertonia, Hepatomegaly, Opacification of the corneal stroma, Hemiplegia/hemiparesis.

How is it diagnosed?

To find out if someone has a diagnosis of Mucopolysaccharidoses, it is important to have a consultation and evaluation with a clinical genetic specialist.  Specialists may also suggest specific genetic testing or other types of tests to help reach a diagnosis.  FDNA’s AI technology can help speed up the diagnostic process by analyzing facial features and other health information.  

More syndromes

Syndromes & Disorders

Ankyloblepharon-Ectodermal Defects-Cleft Lip/Palate Syndrome: Symptoms, Causes, Diagnosis, and Management 

Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome, often shortened to AEC syndrome and also known as Hay-Wells syndrome, is a rare genetic condition that combines fused eyelids at birth with widespread skin, hair, and dental changes. AEC syndrome is an extremely rare ectodermal dysplasia that has been reported in a limited number of individuals worldwide. Because severe skin erosions in infancy […]

Read more
Syndromes & Disorders

Cranioectodermal Dysplasia: Symptoms, Causes, Diagnosis, and Treatment 

Cranioectodermal dysplasia, also known as Sensenbrenner syndrome, is a rare genetic ciliopathy that can affect the skull, skeleton, hair, teeth, nails, skin, kidneys, liver, eyes, and other organs. The combination and severity of features vary between individuals. Doctors first described it in 1975, and fewer than 100 affected individuals have been documented in the medical literature, […]

Read more